Showing results (461-470 of 546) with videos related to
Sort By:
Pageof 55
JAMA Oncology|January 13, 2018
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical TrialLuca Gianni, Mauro Mansutti, Antonio Anton, et al.Geburtshilfe Und Frauenheilkunde|June 13, 2025
Indirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast CancerDiana Lüftner, Maggie Banys-Paluchowski, Andreas D Hartkopf, et al.Anti-Cancer Drugs|March 16, 2019
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)Joachim Bischoff, Jana Barinoff, Christoph Mundhenke, et al.The New England Journal of Medicine|December 12, 2024
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA TrialToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.Biotechnology Progress|November 23, 2012
Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticalsSeshu Tummala, Michael Titus, Lee Wilson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2019
Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) TrialSherko Kuemmel, Johannes Holtschmidt, Bernd Gerber, et al.Medical Physics|December 15, 2022
Quality assurance assessment of intra-acquisition diffusion-weighted and T2-weighted magnetic resonance imaging registration and contour propagation for head and neck cancer radiotherapyMohamed A Naser, Kareem A Wahid, Sara Ahmed, et al.Current Tropical Medicine Reports|June 7, 2021
Human Q Fever on the Guiana Shield and Brazil: Recent Findings and Remaining QuestionsLoïc Epelboin, Carole Eldin, Pauline Thill, et al.Therapeutic Advances in Medical Oncology|December 7, 2020
The run-in phase of the prospective WSG-ADAPT HR+/HER2- trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancerUlrike Nitz, Oleg Gluz, Hans H Kreipe, et al.Geburtshilfe Und Frauenheilkunde|February 16, 2022
Update Breast Cancer 2021 Part 5 - Advanced Breast CancerDiana Lüftner, Florian Schütz, Elmar Stickeler, et al.Pageof 55